- Home
- DHF vs BWAY Comparison
DHF vs BWAY Comparison
Compare DHF & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHF
- BWAY
- Stock Information
- Founded
- DHF 1998
- BWAY 2003
- Country
- DHF United States
- BWAY Israel
- Employees
- DHF N/A
- BWAY N/A
- Industry
- DHF Finance Companies
- BWAY Medical/Dental Instruments
- Sector
- DHF Finance
- BWAY Health Care
- Exchange
- DHF Nasdaq
- BWAY Nasdaq
- Market Cap
- DHF 188.4M
- BWAY 177.4M
- IPO Year
- DHF N/A
- BWAY 2019
- Fundamental
- Price
- DHF $2.60
- BWAY $10.28
- Analyst Decision
- DHF
- BWAY Strong Buy
- Analyst Count
- DHF 0
- BWAY 3
- Target Price
- DHF N/A
- BWAY $13.17
- AVG Volume (30 Days)
- DHF 451.1K
- BWAY 57.5K
- Earning Date
- DHF 01-01-0001
- BWAY 03-05-2025
- Dividend Yield
- DHF 7.65%
- BWAY N/A
- EPS Growth
- DHF N/A
- BWAY N/A
- EPS
- DHF N/A
- BWAY 0.04
- Revenue
- DHF N/A
- BWAY $38,631,000.00
- Revenue This Year
- DHF N/A
- BWAY $388.82
- Revenue Next Year
- DHF N/A
- BWAY $18.70
- P/E Ratio
- DHF N/A
- BWAY $128.37
- Revenue Growth
- DHF N/A
- BWAY 34.19
- 52 Week Low
- DHF $2.06
- BWAY $4.61
- 52 Week High
- DHF $2.39
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- DHF 53.08
- BWAY 46.35
- Support Level
- DHF $2.53
- BWAY $10.24
- Resistance Level
- DHF $2.62
- BWAY $10.89
- Average True Range (ATR)
- DHF 0.03
- BWAY 0.47
- MACD
- DHF 0.00
- BWAY -0.04
- Stochastic Oscillator
- DHF 50.00
- BWAY 10.34
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.